Filing Details
- Accession Number:
- 0001209191-17-037298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-02 16:39:58
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-02
- Accepted Time:
- 2017-06-02 16:39:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
893949 | Mednax Inc. | MD | Services-Hospitals (8060) | 263667538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1443082 | A. David Clark | 1301 Concord Terrace Sunrise FL 33323 | Pres. Mednax Natl Med Group | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-01 | 15,277 | $0.00 | 35,302 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-06-01 | 10,202 | $54.99 | 25,100 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.
- Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.